Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 2654520, 9 pages
https://doi.org/10.1155/2017/2654520
Research Article

Liver-Specific Overexpression of Gamma-Glutamyltransferase Ameliorates Insulin Sensitivity of Male C57BL/6 Mice

1Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu 610041, China
2Laboratory of Endocrinology, Experimental Medicine Center, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
3Division of General Practice, West China Hospital of Sichuan University, Chengdu 610041, China
4Department of Stomatology, Hebei Medical University Affiliated North China Petroleum Bureau General Hospital, Renqiu 062552, China
5Health Examination Management Center, Sichuan Province People’s Hospital, Chengdu 610072, China

Correspondence should be addressed to Haoming Tian; moc.621@999naitmh and Tao Chen; moc.qq@oatnehc.rd

Received 8 February 2017; Revised 18 April 2017; Accepted 4 May 2017; Published 4 June 2017

Academic Editor: Joseph F. Ndisang

Copyright © 2017 Yang Long et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D.-H. Lee, D. Jacobs, M. Gross et al., “Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study,” Clinical Chemistry, vol. 49, no. 8, pp. 1358–1366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Nakanishi, K. Suzuki, and K. Tatara, “Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men,” Diabetes Care, vol. 27, no. 6, pp. 1427–1432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Kunutsor, A. Abbasi, and A. I. Adler, “Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis,” Annals of Epidemiology, vol. 24, no. 11, pp. 809–816, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Andre, B. Balkau, C. Born, M. A. Charles, E. Eschwege, and Group DESIRs, “Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort,” Diabetologia, vol. 49, no. 11, pp. 2599–2603, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. B. Whitfield, “Gamma glutamyl transferase,” Critical Reviews in Clinical Laboratory Sciences, vol. 38, no. 4, pp. 263–355, 2001. View at Publisher · View at Google Scholar
  6. C. Sabanayagam, A. Shankar, J. Li, C. Pollard, and A. Ducatman, “Serum gamma-glutamyl transferase level and diabetes mellitus among US adults,” European Journal of Epidemiology, vol. 24, no. 7, pp. 369–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Lawlor, N. Sattar, G. D. Smith, and S. Ebrahim, “The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase,” American Journal of Epidemiology, vol. 161, no. 11, pp. 1081–1088, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Iciek, G. Chwatko, H. Rokita, E. Bald, and L. Wlodek, “The effects of modulation of gamma-glutamyl transpeptidase activity in HepG2 cells on thiol homeostasis and caspase-3-activity,” Biochimica et Biophysica Acta, vol. 1773, no. 2, pp. 201–208, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Chen, Y. Ren, Y. Liu et al., “Serum gamma-glutamyl transferase, ferritin and the risk of type 2 diabetes in women from a Chinese minority,” Diabetes Research and Clinical Practice, vol. 90, no. 3, pp. 352–357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Thamer, O. Tschritter, M. Haap et al., “Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids,” Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme, vol. 37, no. 4, pp. 246–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Wang, J. Zhang, B. Wang et al., “New evidence for an association between liver enzymes and pancreatic islet beta-cell dysfunction in young obese patients,” Endocrine, vol. 44, no. 3, pp. 688–695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Lee and D. R. Jacobs Jr., “Association between serum gamma-glutamyltransferase and C-reactive protein,” Atherosclerosis, vol. 178, no. 2, pp. 327–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. D. Bradley, A. L. Fitzpatrick, D. R. Jacobs Jr., D. H. Lee, N. Swords Jenny, and D. Herrington, “Associations between gamma-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the Multi-ethnic Study of Atherosclerosis (MESA),” Atherosclerosis, vol. 233, no. 2, pp. 387–393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Hiramatsu, Y. Asaba, S. Takeshita et al., “Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis,” Endocrinology, vol. 148, no. 6, pp. 2708–2715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Obrador, J. Carretero, A. Ortega et al., “Gamma-glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver,” Hepatology, vol. 35, no. 1, pp. 74–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. X. Zhang, G. D. Xiang, L. Xiang, and J. Dong, “Serum gamma-glutamyl transferase is associated with the elevated uric acid levels in normotensive Chinese adults,” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 441, pp. 122–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhao, S. Li, G. Liu et al., “Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis,” PLoS One, vol. 7, no. 7, article e41641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Sluijs, J. W. Beulens, A. D. van der, A. M. Spijkerman, M. B. Schulze, and Y. T. van der Schouw, “Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors,” The Journal of Nutrition, vol. 143, no. 1, pp. 80–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Wang, W. Bao, J. Liu et al., “Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis,” Diabetes Care, vol. 36, no. 1, pp. 166–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Koenig and S. Seneff, “Gamma-glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk,” Disease Markers, vol. 2015, Article ID 818570, p. 18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. B. Sridhar, F. Xu, J. Darbinian, C. P. Quesenberry, A. Ferrara, and M. M. Hedderson, “Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy,” Diabetes Care, vol. 37, no. 7, pp. 1878–1884, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Manna and S. K. Jain, “Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Czeta/lambda (PKCzeta/lambda) in 3T3l1 adipocytes,” The Journal of Biological Chemistry, vol. 286, no. 46, pp. 39848–39859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Manna and S. K. Jain, “L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARgamma expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes,” Journal of Cellular Biochemistry, vol. 114, no. 10, pp. 2334–2345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Gawlik, J. W. Naskalski, D. Fedak et al., “Markers of antioxidant defense in patients with type 2 diabetes,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2352361, p. 6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. M. S. Al-Dosari, J. E. Knapp, and D. Liu, “Hydrodynamic delivery,” Advances in Genetics, vol. 54, pp. 65–82, 2005. View at Publisher · View at Google Scholar · View at Scopus